SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bristol-Myers Squibb Co. – ‘10-K’ for 12/31/23

On:  Tuesday, 2/13/24, at 11:54am ET   ·   For:  12/31/23   ·   Accession #:  14272-24-44   ·   File #:  1-01136

Previous ‘10-K’:  ‘10-K’ on 2/14/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   34 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/13/24  Bristol-Myers Squibb Co.          10-K       12/31/23  148:22M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.75M 
 3: EX-10.BB    Rsu Agreement With 5-Year Vesting Under the 2021    HTML    280K 
                Stock Award and Incentive Plan                                   
 4: EX-10.CC    Rsu Agreement With 4-Year Vesting Under the 2021    HTML    284K 
                Stock Award and Incentive Plan                                   
 5: EX-10.DD    Rsu Agreement With 3-Year Vesting Under the 2021    HTML    280K 
                Stock Award and Incentive Plan                                   
 6: EX-10.EE    Rsu Agreement With 2-Year Vesting Under the 2021    HTML    274K 
                Stock Award and Incentive Plan                                   
 7: EX-10.FF    Rsu Agreement With 1-Year Vesting Under the 2021    HTML    274K 
                Stock Award and Incentive Plan                                   
 8: EX-10.GG    Msu Agreement Under the 2021 Stock Award and        HTML    311K 
                Incentive Plan                                                   
 2: EX-10.I     Psu Award Agreement Under the 2021 Stock Award and  HTML    319K 
                Incentive Plan                                                   
 9: EX-19       Report Furnished to Security Holders                HTML     84K 
10: EX-21       Subsidiaries List                                   HTML    147K 
11: EX-23       Consent of Expert or Counsel                        HTML     38K 
16: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     60K 
                Awarded Compensation                                             
12: EX-31.A     Certification -- §302 - SOA'02                      HTML     43K 
13: EX-31.B     Certification -- §302 - SOA'02                      HTML     43K 
14: EX-32.A     Certification -- §906 - SOA'02                      HTML     40K 
15: EX-32.B     Certification -- §906 - SOA'02                      HTML     40K 
22: R1          Cover Page                                          HTML    115K 
23: R2          Audit Information                                   HTML     44K 
24: R3          Consolidated Statements of Earnings                 HTML    118K 
25: R4          Consolidated Statements of Comprehensive Income     HTML     81K 
26: R5          Consolidated Balance Sheets                         HTML    165K 
27: R6          Consolidated Balance Sheets (Parenthetical)         HTML     62K 
28: R7          Consolidated Statements of Cash Flows               HTML    135K 
29: R8          Accounting Policies and Recently Issued Accounting  HTML     81K 
                Standards                                                        
30: R9          Revenue                                             HTML    134K 
31: R10         Alliances                                           HTML    112K 
32: R11         Acquisitions, Divestitures, Licensing and Other     HTML    116K 
                Arrangements                                                     
33: R12         Other (Income)/Expense, Net                         HTML     68K 
34: R13         Restructuring                                       HTML     82K 
35: R14         Income Taxes                                        HTML    188K 
36: R15         Earnings/(Loss) Per Share                           HTML     54K 
37: R16         Financial Instruments and Fair Value Measurements   HTML    179K 
38: R17         Financing Arrangements                              HTML    117K 
39: R18         Receivables                                         HTML     61K 
40: R19         Inventories                                         HTML     49K 
41: R20         Property, Plant and Equipment                       HTML     55K 
42: R21         Leases                                              HTML     73K 
43: R22         Goodwill and Other Intangible Assets                HTML     75K 
44: R23         Supplemental Financial Information                  HTML     83K 
45: R24         Equity                                              HTML    200K 
46: R25         Retirement Benefits                                 HTML    151K 
47: R26         Employee Stock Benefit Plans                        HTML    128K 
48: R27         Legal Proceedings and Contingencies                 HTML    108K 
49: R28         Pay vs Performance Disclosure                       HTML     51K 
50: R29         Insider Trading Arrangements                        HTML     45K 
51: R30         Accounting Policies and Recently Issued Accounting  HTML    143K 
                Standards (Policies)                                             
52: R31         Accounting Policies and Recently Issued Accounting  HTML     49K 
                Standards (Tables)                                               
53: R32         Revenue (Tables)                                    HTML    126K 
54: R33         Alliances (Tables)                                  HTML     89K 
55: R34         Acquisitions, Divestitures, Licensing and Other     HTML    102K 
                Arrangements (Tables)                                            
56: R35         Other (Income)/Expense, Net (Tables)                HTML     62K 
57: R36         Restructuring (Tables)                              HTML     82K 
58: R37         Income Taxes (Tables)                               HTML    187K 
59: R38         Earnings/(Loss) Per Share (Tables)                  HTML     54K 
60: R39         Financial Instruments and Fair Value Measurements   HTML    175K 
                (Tables)                                                         
61: R40         Financing Arrangements (Tables)                     HTML    113K 
62: R41         Receivables (Tables)                                HTML     63K 
63: R42         Inventories (Tables)                                HTML     50K 
64: R43         Property, Plant and Equipment (Tables)              HTML     54K 
65: R44         Leases (Tables)                                     HTML     73K 
66: R45         Goodwill and Other Intangible Assets (Tables)       HTML     74K 
67: R46         Supplemental Financial Information (Tables)         HTML     88K 
68: R47         Equity (Tables)                                     HTML    198K 
69: R48         Retirement Benefits (Tables)                        HTML    147K 
70: R49         Employee Stock Benefit Plans (Tables)               HTML    125K 
71: R50         ACCOUNTING POLICIES AND RECENTLY ISSUED ACCOUNTING  HTML     80K 
                STANDARDS - Narrative (Details)                                  
72: R51         ACCOUNTING POLICIES AND RECENTLY ISSUED ACCOUNTING  HTML     47K 
                STANDARDS - Acquired IPRD By Type of Transaction                 
                (Details)                                                        
73: R52         REVENUE - Disaggregation of Revenue (Details)       HTML     55K 
74: R53         REVENUE - Narrative (Details)                       HTML     48K 
75: R54         REVENUE - Schedule of Revenue by Major Customers    HTML     50K 
                (Details)                                                        
76: R55         REVENUE - Reconciliation of Gross Product Sales to  HTML     62K 
                Net Product Sales (Details)                                      
77: R56         REVENUE - Disaggregation of Revenue by Product and  HTML    102K 
                Region (Details)                                                 
78: R57         ALLIANCES - Financial Information Pertaining to     HTML     79K 
                Alliances (Total) (Details)                                      
79: R58         ALLIANCES - Financial Information Pertaining to     HTML     46K 
                Alliances (SystImmune) (Details)                                 
80: R59         ALLIANCES - Financial Information Pertaining to     HTML     84K 
                Alliances (Pfizer) (Details)                                     
81: R60         ALLIANCES - Financial Information Pertaining to     HTML     72K 
                Alliances (Ono) (Details)                                        
82: R61         ALLIANCES - Financial Information Pertaining to     HTML     44K 
                Alliances (BridgeBio) (Details)                                  
83: R62         ALLIANCES - Financial Information Pertaining to     HTML     61K 
                Alliances (2Seventy Bio) (Details)                               
84: R63         ALLIANCES - Financial Information Pertaining to     HTML     45K 
                Alliances (Eisai) (Details)                                      
85: R64         ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER     HTML    156K 
                ARRANGEMENTS - Narrative (Details)                               
86: R65         ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER     HTML     54K 
                ARRANGEMENTS - Schedule of Consideration                         
                Transferred (Details)                                            
87: R66         ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER     HTML     71K 
                ARRANGEMENTS - Schedule of Recognized Identified                 
                Assets Acquired and Liabilities Assumed (Details)                
88: R67         ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER     HTML     55K 
                ARRANGEMENTS - Divestitures (Details)                            
89: R68         ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER     HTML     59K 
                ARRANGEMENTS - Licensing and Other Arrangements                  
                (Details)                                                        
90: R69         Other (INCOME)/EXPENSE, NET - Schedule Of Other     HTML     69K 
                Income Expense (Details)                                         
91: R70         Other (INCOME)/EXPENSE, NET - Narrative (Details)   HTML     74K 
92: R71         RESTRUCTURING - Narrative (Details)                 HTML     49K 
93: R72         RESTRUCTURING - Schedule of Restructuring and       HTML     73K 
                Related Costs (Details)                                          
94: R73         RESTRUCTURING - Schedule of Restructuring Reserve   HTML     50K 
                by Type of Cost (Details)                                        
95: R74         INCOME TAXES - Schedule of Provision for Income     HTML     61K 
                Taxes (Details)                                                  
96: R75         INCOME TAXES - Schedule of Effective Income Tax     HTML    120K 
                Rate Reconciliation (Details)                                    
97: R76         INCOME TAXES - Narrative (Details)                  HTML     84K 
98: R77         INCOME TAXES - Schedule of Deferred Tax Assets and  HTML     77K 
                Liabilities (Details)                                            
99: R78         INCOME TAXES - Summary of Valuation Allowance       HTML     55K 
                (Details)                                                        
100: R79         INCOME TAXES - Summary of Income Tax Contingencies  HTML     59K  
                (Details)                                                        
101: R80         INCOME TAXES - Summary of Income Tax Examinations   HTML     47K  
                (Details)                                                        
102: R81         Earnings/(Loss) Per Share (Details)                 HTML     73K  
103: R82         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML    107K  
                - Schedule of Financial Assets and Liabilities                   
                Measured at Fair Value (Details)                                 
104: R83         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML     48K  
                - Summary of Equity Investments Carrying Amount                  
                (Details)                                                        
105: R84         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML     57K  
                - Schedule of Equity Investments (Details)                       
106: R85         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML     71K  
                - Narrative (Details)                                            
107: R86         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML     97K  
                - Schedule of Derivatives and Fair Value (Details)               
108: R87         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML     53K  
                - Derivative Instruments, Gain (Loss) (Details)                  
109: R88         FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS   HTML     74K  
                - Gain/(Loss) on Hedging Activity (Details)                      
110: R89         FINANCING ARRANGEMENTS - Short-Term Debt (Details)  HTML     48K  
111: R90         FINANCING ARRANGEMENTS - Long-Term Debt (Details)   HTML    177K  
112: R91         FINANCING ARRANGEMENTS - Narrative (Details)        HTML    122K  
113: R92         RECEIVABLES - Schedule of Accounts, Notes, Loans    HTML     52K  
                and Financing Receivable (Details)                               
114: R93         RECEIVABLES - Additional Information (Details)      HTML     46K  
115: R94         RECEIVABLES - Receivables Allowance (Details)       HTML     50K  
116: R95         Inventories (Details)                               HTML     57K  
117: R96         Property, Plant and Equipment (Details)             HTML     62K  
118: R97         LEASES - Narrative (Details)                        HTML     62K  
119: R98         LEASES - Summary of Components of Lease Expense     HTML     50K  
                (Details)                                                        
120: R99         LEASES - Balance Sheet Information Related to       HTML     53K  
                Leases (Details)                                                 
121: R100        LEASES - Summary of Operating Lease Maturity        HTML     58K  
                (Details)                                                        
122: R101        LEASES - Supplemental Balance Sheet Information     HTML     43K  
                Related To Leases (Details)                                      
123: R102        GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of  HTML     50K  
                Goodwill (Details)                                               
124: R103        GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of  HTML     76K  
                Intangible Assets (Details)                                      
125: R104        GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative    HTML     83K  
                (Details)                                                        
126: R105        SUPPLEMENTAL FINANCIAL INFORMATION - Other Current  HTML     53K  
                Assets (Details)                                                 
127: R106        SUPPLEMENTAL FINANCIAL INFORMATION - Other          HTML     58K  
                Non-Current Assets (Details)                                     
128: R107        SUPPLEMENTAL FINANCIAL INFORMATION - Other Current  HTML     59K  
                Liabilities (Details)                                            
129: R108        SUPPLEMENTAL FINANCIAL INFORMATION - Other          HTML     54K  
                Non-Current Liabilities (Details)                                
130: R109        EQUITY - Schedule of Stockholders Equity (Details)  HTML    106K  
131: R110        EQUITY - Narrative (Details)                        HTML     60K  
132: R111        EQUITY - Schedule of Comprehensive Income (Loss)    HTML    128K  
                (Details)                                                        
133: R112        EQUITY - Schedule of Accumulated Other              HTML     55K  
                Comprehensive Income (Loss) (Details)                            
134: R113        RETIREMENT BENEFITS - Narrative (Details)           HTML     64K  
135: R114        RETIREMENT BENEFITS - Schedule Of Defined Benefit   HTML    100K  
                Obligations And Assets (Details)                                 
136: R115        RETIREMENT BENEFITS - Schedule Of Accumulated And   HTML     51K  
                Projected Benefit Obligation In Excess Of Fair                   
                Value Of Plan Assets (Details)                                   
137: R116        RETIREMENT BENEFITS - Actuarial Assumptions         HTML     57K  
                (Details)                                                        
138: R117        RETIREMENT BENEFITS - Fair Value of Pension Plan    HTML    100K  
                Assets by Asset Category (Details)                               
139: R118        EMPLOYEE STOCK BENEFIT PLANS - Narrative (Details)  HTML     79K  
140: R119        EMPLOYEE STOCK BENEFIT PLANS - Stock Based          HTML     63K  
                Compensation Expense (Details)                                   
141: R120        EMPLOYEE STOCK BENEFIT PLANS - Summary of Stock     HTML    135K  
                Compensation Activity (Details)                                  
142: R121        EMPLOYEE STOCK BENEFIT PLANS - Summary of           HTML     80K  
                Significant Outstanding and Exercisable Options                  
                (Details)                                                        
143: R122        Legal Proceedings and Contingencies (Details)       HTML    115K  
145: XML         IDEA XML File -- Filing Summary                      XML    262K  
148: XML         XBRL Instance -- bmy-20231231_htm                    XML   4.95M  
144: EXCEL       IDEA Workbook of Financial Report Info              XLSX    310K  
18: EX-101.CAL  XBRL Calculations -- bmy-20231231_cal                XML    463K 
19: EX-101.DEF  XBRL Definitions -- bmy-20231231_def                 XML   1.47M 
20: EX-101.LAB  XBRL Labels -- bmy-20231231_lab                      XML   3.66M 
21: EX-101.PRE  XBRL Presentations -- bmy-20231231_pre               XML   2.23M 
17: EX-101.SCH  XBRL Schema -- bmy-20231231                          XSD    362K 
146: JSON        XBRL Instance as JSON Data -- MetaLinks              943±  1.42M  
147: ZIP         XBRL Zipped Folder -- 0000014272-24-000044-xbrl      Zip   1.39M  




        
Filing Submission 0000014272-24-000044 – SGML Text

Original SGML Text submitted by:  Bristol-Myers Squibb Co.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:48:39.4pm ET